UBS strategist Joni Teves is breaking her own rules — so are strategists at Goldman Sachs.
In a report released today, Michele Della Vigna from Goldman Sachs maintained a Buy rating on ENI S.p.A. (0N9S – Research Report), with a price ...
UBS analyst Matthew Weston maintained a Buy rating on Merck KGaA (0O14 – Research Report) today and set a price target of €190.00. The ...
Sempra (SRE) rebounds after a steep drop, as Goldman Sachs and UBS downgrade shares citing reduced guidance, uncertainty in growth, and regulatory risks.
UBS strategist Joni Teves is breaking her own rules - so are strategists at Goldman Sachs. "It is always tricky to chase the market higher and uncomfortable when everyone seems to be on the same ...
New banking rules for UBS could face a long delay after Switzerland's finance ministry on Wednesday said it wanted lawmakers ...
Goldman Sachs' CEO touched on the growth around the firm's private wealth management platform and how the market is ...
Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...
Gold's (GC=F) glittering run in 2025 may have more room to rise higher, Goldman Sachs believes. On Tuesday, the investment ...
Symbotic (NASDAQ:SYM – Get Free Report) had its price target dropped by analysts at UBS Group from $32.00 to $30.00 in a research report issued to clients and investors on Tuesday,Benzinga reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results